R
Robby Nieuwlaat
Researcher at McMaster University
Publications - 145
Citations - 20993
Robby Nieuwlaat is an academic researcher from McMaster University. The author has contributed to research in topics: Atrial fibrillation & Guideline. The author has an hindex of 42, co-authored 134 publications receiving 17686 citations. Previous affiliations of Robby Nieuwlaat include University of Pittsburgh & Maastricht University Medical Centre.
Papers
More filters
Journal ArticleDOI
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
TL;DR: In this article, a simple stroke risk stratifi cation schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS 2 schema, with low event rates in low-risk subjects and only a small proportion of subjects into the intermediate-risk category.
Journal ArticleDOI
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Ron Pisters,Deirdre A. Lane,Robby Nieuwlaat,Cees B. de Vos,Harry J.G.M. Crijns,Gregory Y.H. Lip +5 more
TL;DR: This simple, novel bleeding risk score (HAS-BLED) provides a practical tool to assess the individual bleeding risk of real-world patients withAF, potentially supporting clinical decision making regarding antithrombotic therapy in patients with AF.
Journal ArticleDOI
Interventions for enhancing medication adherence.
Robby Nieuwlaat,Nancy L. Wilczynski,Tamara Navarro,Nicholas Hobson,Rebecca A. Jeffery,Arun Keepanasseril,Thomas Agoritsas,Niraj Mistry,Alfonso Iorio,Susan M. Jack,Bhairavi Sivaramalingam,Emma Iserman,Reem A. Mustafa,Dawn Jedraszewski,Chris Cotoi,R. Brian Haynes +15 more
TL;DR: The research in this field needs advances, including improved design of feasible long-term interventions, objective adherence measures, and sufficient study power to detect improvements in patient-important clinical outcomes.
Journal ArticleDOI
Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation
Robby Nieuwlaat,Alessandro Capucci,A. John Camm,S. Bertil Olsson,Dietrich Andresen,D. Wyn Davies,Stuart M. Cobbe,Günter Breithardt,Jean-Yves Le Heuzey,Martin H. Prins,Samuel Lévy,Harry J.G.M. Crijns +11 more
TL;DR: This survey provides a unique snapshot of current AF management in ESC member countries and found Discordance between guidelines and practice was found regarding several issues on stroke prevention and antiarrhythmic therapy.
Journal ArticleDOI
Progression From Paroxysmal to Persistent Atrial Fibrillation: Clinical Correlates and Prognosis
Cees B. de Vos,Ron Pisters,Robby Nieuwlaat,Martin H. Prins,Robert G. Tieleman,Robert-Jan S. Coelen,Antonius C. van den Heijkant,Maurits A. Allessie,Harry J.G.M. Crijns +8 more
TL;DR: In this paper, clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population were investigated and a substantial number of patients progress to sustained AF within 1 year.